NCT03509324View on ClinicalTrials.gov

Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

March 1, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Insulin LISPRO

receive short-term insulin pump therapy by using insulin LISPRO, continue treatment for 7 more days when euglycemia achieved

Trial Locations (1)

510080

endocrinology department of the first affiliated hospital of Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT03509324 - Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 Diabetes | Biotech Hunter | Biotech Hunter